Overview
US Stock Market
Technology
Financial
Real Estate
Energy
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Healthcare
Industrials
Utilities
Other Symbols
Currencies
Major
Minor
America
Europe
Asia
Cryptocurrencies
Metals
Indexes
Commodities
Charts
WidgetsARCT: Arcturus Therapeutics Holdings Inc
ARCT exchange rate has changed by 1.28% for today. During the day, the instrument was traded at a low of 11.05 and at a high of 11.34.
Follow Arcturus Therapeutics Holdings Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ARCT News
- Transcript: Arcturus Therapeutics Q2 2026 Earnings Conference Call
- Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
- CrowdStrike To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday
- Leerink Partners Maintains Outperform on Arcturus Therapeutics, Raises Price Target to $19
- 4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
- Why Is Arcturus Therapeutics Stock Gaining Thursday?
- Citigroup Upgrades Arcturus Therapeutics to Buy, Raises Price Target to $20
- Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday
- BTIG Maintains Buy on Arcturus Therapeutics, Lowers Price Target to $20
- Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
- Arcturus Therapeutics Holdings Inc. (ARCT) Discusses Phase II Data for OTC Deficiency and Advances in mRNA Liver Therapeutics Platform - Slideshow (NASDAQ:ARCT) 2026-09-24
- Arcturus Therapeutics Holdings Inc. (ARCT) Discusses Phase II Data for OTC Deficiency and Advances in mRNA Liver Therapeutics Platform Transcript
- Arcturus Therapeutics Says ARCT-810 Generally Safe And Well Tolerated, Demonstrating Encouraging Activity Across Key Urea Cycle Biomarkers In Ongoing Phase 2 Study
- Arcturus To Acquire myNEO, An AI Discovery Company, To Improve mRNA Design Quality, Accelerate Innovation, And Enhance Target Identification Capability; No Financial Terms Disclosed; Co To Host Presentation At 4:30 p.m. ET today
- Arcturus Therapeutics Announces Interim Phase 2 Results From ARCT-810 In OTC Deficienc And Introduces LUNAR 2.0
- Arcturus Therapeutics: A Speculative Buy For Their OTC Deficiency Program (NASDAQ:ARCT)
- Arcturus Therapeutics To Present Overview Of ARCT-810 Phase 2 Clinical Program For Ornithine Transcarbamylase Deficiency And Arcturus’ mRNA Liver Therapeutics Platform On Sept. 23
- Broadcom, Palo Alto Networks Headline Earnings Amid A Tight Economic Calendar
- Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?
- Elon Musk Backs mRNA As Moderna's Stock Soars on Cancer Vaccine Win - Moderna (NASDAQ:MRNA)
- Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates
- Exelixis (EXEL) Tops Q2 Earnings Estimates
- PTC Therapeutics (PTCT) Beats Q2 Earnings and Revenue Estimates
- Arcturus: Now That It's Come This Low, It's Time To Buy And Hold (NASDAQ:ARCT)
Frequently Asked Questions
What is ARCT stock price today?
Arcturus Therapeutics Holdings Inc stock is priced at 11.12 today. It trades within 11.05 - 11.34, yesterday's close was 10.98, and trading volume reached 452. The live price chart of ARCT shows these updates.
Does Arcturus Therapeutics Holdings Inc stock pay dividends?
Arcturus Therapeutics Holdings Inc is currently valued at 11.12. Dividend policy depends on the company, while investors also watch 10.32% and USD. View the chart live to track ARCT movements.
How to buy ARCT stock?
You can buy Arcturus Therapeutics Holdings Inc shares at the current price of 11.12. Orders are usually placed near 11.12 or 11.42, while 452 and 0.09% show market activity. Follow ARCT updates on the live chart today.
How to invest into ARCT stock?
Investing in Arcturus Therapeutics Holdings Inc involves considering the yearly range 5.50 - 17.96 and current price 11.12. Many compare -17.57% and 29.91% before placing orders at 11.12 or 11.42. Explore the ARCT price chart live with daily changes.
What are Arcturus Therapeutics Holdings Inc stock highest prices?
The highest price of Arcturus Therapeutics Holdings Inc in the past year was 17.96. Within 5.50 - 17.96, the stock fluctuated notably, and comparing with 10.98 helps spot resistance levels. Track Arcturus Therapeutics Holdings Inc performance using the live chart.
What are Arcturus Therapeutics Holdings Inc stock lowest prices?
The lowest price of Arcturus Therapeutics Holdings Inc (ARCT) over the year was 5.50. Comparing it with the current 11.12 and 5.50 - 17.96 shows potential long-term entry points. Watch ARCT moves on the chart live for more details.
When did ARCT stock split?
Arcturus Therapeutics Holdings Inc has gone through stock splits historically. These changes are visible in , 10.98, and 10.32% after corporate actions.
- Previous Close
- 10.98
- Open
- 11.11
- Bid
- 11.12
- Ask
- 11.42
- Low
- 11.05
- High
- 11.34
- Volume
- 452
- Daily Change
- 1.28%
- Month Change
- -17.57%
- 6 Months Change
- 29.91%
- Year Change
- 10.32%
- Act
- -3.060 M
- Fcst
- -4.804 M
- Prev
- -8.557 M
- Act
- 0.987 M
- Fcst
- -0.153 M
- Prev
- 1.862 M
- Act
- Fcst
- Prev
- 5.420%